Scientific Programme

Some of these sessions have been sponsored by industry. They have had no involvement in the development of the content.

Thursday, March 19th, 2026
  MM 4+5+6  Hall MM 01 Hall
13:00 – 14:00 ILD/IPF
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 338 415 727 550 11
Passcode: DH9HL2AH
Adherence
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 348 801 284 964 1
Passcode: 7Hy34yb6
14:00 – 15:00 Allergy
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 324 285 423 800 86 
Passcode: DM2FS2AC
COPD
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 345 111 137 475 18 
Passcode: Yb3mo2kZ
15:00 – 16:00 Technologies
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 314 487 284 837 68 
Passcode: P78s2au6
Child Health
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 396 418 851 150 4
Passcode: DR2gT2dY
16:00 – 16:30 Coffee Break
16:30 – 17:30 Cost Effectiveness
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 316 219 594 824 77
Passcode: P7g7iT9J
Database & Coding
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 333 448 030 781 53
Passcode: ND6jP76q
17:30 – 18:30 Environment, Epidemiology & Airways
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID:  312 124 842 998 68 
Passcode: sa38km7t
Biomarkers & Severe Asthma
Please click HERE to view the working group agenda

Please click HERE to join via TEAMS
Meeting ID: 370 522 091 148 51 
Passcode: E77he7B8
Friday, March 20th, 2026
   MM 07 Hall
08:50 – 08:55 Welcome
Joan Β. Soriano, REG President
08:55 – 10:25 Environment Session – Exposures in real life
Chair: Nikos Papadopoulos

Controlling indoor air pollution - a midsummer night's dream
Athanasios Nenes

Who cares about pollen?
Maria P. Plaza

Breathing nanoplastics - how does it feel?
Carlos Baeza-Martínez
Q&A
10:25 – 10:45 Coffee Break
10:45 – 11:55 Session - Global Respiratory Health Perspectives
Chair: Dermot Ryan

Respiratory patients’ initiatives in a changing environment
Pippa Powell

IPCRG initiatives on global respiratory health
Cláudia Vicente

ERS perspective on global respiratory health
Marc Miravitlles

GINA & GOLD perspective on global respiratory health
David Halpin

Q&A
11:55 – 12:40 ILD/IPF Session
Chair: Katerina Antoniou

Can RWE help bring new ILD/IPF therapies to patients?
Michael Gibbons

Q & A
12:40 – 13:30 Lunch Break
13:30 – 15:00 COPD Session - Challenging current COPD management
Chair: Antonio Anzueto

T2-directed therapy in COPD - is this really the right approach?
Nicolas Roche

ICS - do they really modulate cardiovascular risk?
Konstantinos Kostikas

Introducing ICRA and first project: Data standards for multiple long-term conditions in patients with COPD – results of the Delphi
Chris Gale

Q & A
15:00 – 15:20 Coffee Break
15:20 – 16:30 Early Career Travel Grant Winners
Chair: Alan Kaplan & Joan B. Soriano
6 (approx) x 5min presentations with Q & A for each

In the Respiratory hot seat – PRO & CONs
16:30 – 17:15 Biologics in asthma are disease-modifying
Chair: Arnaud Bourdin

PRO: Florence Schleich
CON: Christian Virchow
17:15 – 18:00 There is value in making an early diagnosis of COPD
Chair: Therese Lapperre

PRO: Klaus Rabe
CON: Miguel Román
Saturday, March 21st, 2026
   MM 07 Hall
09:00 – 10:15 Remission in severe asthma – Insights from the International Severe Asthma Registry (ISAR)
Chair: David Price & Diahn-Warng Perng 

Impact of remission on long-term clinical outcomes of patients with severe asthma (SPOTLIGHT)
Michael E. Wechsler & Ghislaine Scelo

Impact of earlier access to biologics on remission and natural course of asthma (GLEAM)
George Christoff & John Busby

Relapse and its predictors among ISAR patients in remission 12 months after initiating biologics (SHINE)
Luis Pérez-de-Llano & William Oswald

ISAR's practice change goals in severe asthma, including the elimination of long-term OCS use (ENLIGHTEN)
Giorgio Walter Canonica & Dominic A. Friston
10:15 – 10:30 Coffee Break
10:30 – 12:00 Novel approaches to patient management
Chair: Walter Canonica

AIT and biologics – a new treatment option?
Désirée Larenas-Linnemann

Small airways (SAD) and oscillometry
Ron Dandurand

Weight management in airways disease
Alan Kaplan

Q & A
12:00 - 12:45 REG-EAACI Joint session
Chairs: Fulvio Braido & María José Torres Jaén

Moderate-severe rhinitis management
Piotr Kuna

Endotyping of CRS – necessity or luxury?
Wytske Fokkens

Q & A
12:45 – 13:30 Transformation of Respiratory Medicine – where are we going?
Chair: Miguel Román

Real-world implementation of science to inform evidence-based respiratory medicine
Hilary Pinnock

Impact of digitalisation
Job van Boven

Phenotyping asthma/COPD exacerbations in real-life to target management
Mona Bafadhel
13:30 Meeting Close